National Health (Listed drugs on F1 or F2) Amendment Determination 2011 (No.9)
Instrument number PB 60 of 2011
National Health Act 1953
I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the
Minister for Health and Ageing, make this determination under subsection 85AB(1) of the National Health Act 1953.
Dated 29 August 2011
ADRIANA PLATONA
Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health and Ageing
Part 1 Preliminary
1 Name of Determination
(1) This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2011(No.9).
(2) This Determination may also be cited as PB 60 of 2011.
2 Commencement
This Determination commences on 1 September 2011.
3 Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1 Amendments
(Section 3)
[1] Schedule 1, after item dealing with Ambrisentan
Omit
Amiloride
[2] Schedule 1, after item dealing with Clostridium botulinum toxin type A toxin-haemagglutinin complex
Omit
Clotrimazole
[3] Schedule 1, after item dealing with Fenofibrate
Insert
Ferrous Fumarate
Omit
Ferrous sulphate
Insert
Ferrous Sulfate
Insert
Fingolimod
[4] Schedule 1, after item dealing with Nedocromil
Omit
Neomycin
[5] Schedule 1, after item dealing with Strontium
Omit
Sulindac
[6] Schedule 1, after item dealing with Zonisamide
Insert
Zuclopenthixol Decanoate
Note
1. All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See http://www.frli.gov.au.
